Abstract:Background: Melanocortin 1 receptor (MC1R), a receptor of α-melanocyte-stimulating hormone (α-MSH), is exclusively present in melanocytes where α-MSH/MC1R stimulate melanin pigmentation through microphthalmia-associated transcription factor M (MITF-M). Toll-like receptor 4 (TLR4), a receptor of endotoxin lipopolysaccharide (LPS), is distributed in immune and other cell types including melanocytes where LPS/TLR4 activate transcriptional activity of nuclear factor (NF)-κB to express cytokines in innate immunity. LPS/TLR4 also up-regulate MITF-M-target melanogenic genes in melanocytes. Here, we propose a molecular target of antimelanogenic activity through elucidating inhibitory mechanism on α-MSH-induced melanogenic programs by benzimidazole-2-butanol (BI2B), an inhibitor of LPS/TLR4-activated transcriptional activity of NF-κB. Methods: Ultraviolet B (UV-B)-irradiated skins of HRM-2 hairless mice and α-MSH-activated melanocyte cultures were employed to examine melanogenic programs. Results: Topical treatment with BI2B ameliorated UV-B-irradiated skin hyperpigmentation in mice. BI2B suppressed the protein or mRNA levels of melanogenic markers, such as tyrosinase (TYR), MITF-M and proopiomelanocortin (POMC), in UV-B-exposed and pigmented skin tissues. Moreover, BI2B inhibited melanin pigmentation in UV-B-irradiated co-cultures of keratinocyte and melanocyte cells and that in α-MSH-activated melanocyte cultures. Mechanistically, BI2B inhibited the activation of cAMP response element-binding protein (CREB) in α-MSH-induced melanogenic programs and suppressed the expression of MITF-M at the promoter level. As a molecular target, BI2B primarily inhibited mitogen-activated protein kinase (MAPK) kinase 3 (MKK3)-catalyzed kinase activity on p38MAPK. Subsequently, BI2B interrupted downstream pathway of p38MAPK-mitogen and stress-activated protein kinase-1 (MSK1)-CREB-MITF-M, and suppressed MITF-M-target melanogenic genes, encoding enzymes TYR, TYR-related protein-1 (TRP-1) and dopachrome tautomerase (DCT) in melanin biosynthesis, and encoding proteins PMEL17 and Rab27A in the transfer of pigmented melanosomes to the overlaying keratinocytes in the skin. Conclusion: Targeting the MKK3-p38MAPK-MSK1-CREB-MITF-M pathway was suggested as a rationale to inhibit UV-B- or α-MSH-induced facultative melanogenesis and as a strategy to prevent acquired pigmentary disorders in the skin.

P53 Regulates Erk1/2/Creb Cascade Via A Novel Sash1/Map2k2 Crosstalk to Induce Hyperpigmentation

A Novel P53/POMC/Gαs/SASH1 Autoregulatory Feedback Loop Activates Mutated SASH1 to Cause Pathologic Hyperpigmentation

SASH1 impairs melanin synthesis and metastasis by down-regulating the TGF-β signaling pathway

Three mutations in SASH1 cause the pathogenesis of dyschromatosis universalis hereditaria (DUH)

SASH1 Regulates Melanocyte Transepithelial Migration Through a Novel Gαs–SASH1–IQGAP1–E-Cadherin Dependent Pathway

Increased Cul1 Expression Promotes Melanoma Cell Proliferation Through Regulating P27 Expression

The PER3rs772027021 SNP Induces Pigmentation Phenotypes of Dyschromatosis Universalis Hereditaria

DCUN1D1, a new molecule involved in depigmentation via upregulating CXCL10

SASH1 S519N variant links skin hyperpigmentation and premature hair graying to dysfunction of melanocyte lineage

CK1α ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation

SPRY1 Deficiency in Keratinocytes Induces Follicular Melanocyte Stem Cell Migration to the Epidermis Through P53/stem Cell Factor/C-KIT Signaling

Two novel SASH1 mutations in Chinese families with dyschromatosis universalis hereditaria

Melanocortin 1 receptor mediates melanin production by interacting with the BBSome in primary cilia

Epigenetic regulation of melanogenesis

Alpha-melanocyte-stimulating hormone suppresses oxidative stress through a p53-mediated signaling pathway in human melanocytes

Keratinocyte cadherin desmoglein 1 controls melanocyte behavior through paracrine signaling

Targeting phosphorylation circuits on CREB and CRTCs as the strategy to prevent acquired skin hyperpigmentation

Interruption of p38 MAPK -MSK1-CREB-MITF-M pathway to prevent hyperpigmentation in the skin

UV-induced reduction in Polycomb repression promotes epidermal pigmentation

1177 CCN1/Cyr61 Stimulates Melanogenesis Through Integrin Α6β1, P38 MAPK and ERK1/2 Signaling Pathways in Normal Human Epidermal Melanocytes (Nhems)

UCHL1 Regulates Melanogenesis through Controlling MITF Stability in Human Melanocytes